← Research ProtocolsGHK-Cu
STUDIED EXPOSURE MAP / 2018
GHK-Cu
tested in research.
The actual doses, concentrations or exposure levels reported by the source — kept attached to route, population, timeframe and evidence type.
IN VITRO + TOPICAL HUMAN LITERATUREREVIEW / HUMAN DERMAL FIBROBLAST DATASTUDIED EXPOSURE ≠ RECOMMENDED DOSE
STUDIED EXPOSURE / SOURCE DATANumbers below describe this research source only.
0.01 nM
human dermal fibroblasts
1 nM
human dermal fibroblasts
100 nM
human dermal fibroblasts
Context: These are in-vitro concentrations, not an injectable or systemic human dose. The review also describes topical human trials but not as a single standardized systemic exposure.
NOT A DOSING GUIDEENHANCED is reporting what researchers administered or tested. It does not convert these numbers into a personal dose, reconstitution plan, cycle, titration schedule or recommendation.
SOURCE / REVIEW / HUMAN DERMAL FIBROBLAST DATA
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Study design and tested exposure are separated from recommendation. Route and population stay visible so the numbers cannot be read without context.
2018
01 / DESIGNReview including human dermal fibroblast concentration experiments and topical clinical studies
02 / POPULATION / MODELHuman adult dermal fibroblasts; separate topical human studies summarized
03 / ROUTEIn vitro concentration; topical human use summarized separately
04 / TIMEFRAMEStudy-dependent
05 / PRIMARY QUESTIONCollagen/elastin and skin-regeneration-related outcomes
It supports a factual statement about the exposure tested in this research source. It does not establish that the same exposure is appropriate, effective or safe outside that source.
Copper-peptide and tissue biology research
Study exposure ≠ personal protocol. Animal doses are never converted to human-equivalent amounts here. IV, topical, oral, intranasal and subcutaneous exposures are not treated as interchangeable.